Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)

IF 7.6 Q1 ONCOLOGY

Journal of the National Cancer Center Pub Date : 2023-12-01 DOI:10.1016/j.jncc.2023.08.004

Jianchun Duan , Wenfeng Fang , Hairong Xu , Jinliang Wang , Yuan Chen , Yi Ding , Xiaorong Dong , Yun Fan , Beili Gao , Jie Hu , Yan Huang , Cheng Huang , Dingzhi Huang , Wenhua Liang , Lizhu Lin , Hui Liu , Zhiyong Ma , Meiqi Shi , Yong Song , Chuanhao Tang , Jie Wang

{"title":"Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)","authors":"Jianchun Duan , Wenfeng Fang , Hairong Xu , Jinliang Wang , Yuan Chen , Yi Ding , Xiaorong Dong , Yun Fan , Beili Gao , Jie Hu , Yan Huang , Cheng Huang , Dingzhi Huang , Wenhua Liang , Lizhu Lin , Hui Liu , Zhiyong Ma , Meiqi Shi , Yong Song , Chuanhao Tang , Jie Wang","doi":"10.1016/j.jncc.2023.08.004","DOIUrl":null,"url":null,"abstract":"<div><p>Lung cancer is the leading cause of cancer-related deaths worldwide. Bone is a common metastatic site of lung cancer, about 50% of bone metastatic patients will experience skeletal related events (SREs). SREs not only seriously impact the quality of life of patients, but also shorten their survival time. The treatment of bone metastasis requires multi-disciplinary therapy (MDT) and development of individualized treatment plan. In order to standardize the diagnosis and treatment of bone metastasis in lung cancer, the expert group of the MDT Committee of the Chinese Medical Doctor Association has developed the expert consensus on the diagnosis and treatment of lung cancer bone metastasis.</p></div>","PeriodicalId":73987,"journal":{"name":"Journal of the National Cancer Center","volume":"3 4","pages":"Pages 256-265"},"PeriodicalIF":7.6000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667005423000492/pdfft?md5=665a7ce34e38970b91bbf5d9106b2523&pid=1-s2.0-S2667005423000492-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Cancer Center","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667005423000492","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Lung cancer is the leading cause of cancer-related deaths worldwide. Bone is a common metastatic site of lung cancer, about 50% of bone metastatic patients will experience skeletal related events (SREs). SREs not only seriously impact the quality of life of patients, but also shorten their survival time. The treatment of bone metastasis requires multi-disciplinary therapy (MDT) and development of individualized treatment plan. In order to standardize the diagnosis and treatment of bone metastasis in lung cancer, the expert group of the MDT Committee of the Chinese Medical Doctor Association has developed the expert consensus on the diagnosis and treatment of lung cancer bone metastasis.

查看原文本刊更多论文

中国肺癌骨转移诊治专家共识(2022版)

肺癌是全球癌症相关死亡的主要原因。骨是肺癌常见的转移部位，约50%的骨转移患者会经历骨骼相关事件(SREs)。SREs不仅严重影响患者的生活质量，而且缩短患者的生存时间。骨转移的治疗需要多学科治疗(MDT)和制定个性化的治疗方案。为了规范肺癌骨转移的诊疗，中华医师协会MDT委员会专家组制定了《肺癌骨转移诊疗专家共识》。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of the National Cancer Center Oncology

CiteScore

14.20

自引率

0.00%

发文量

审稿时长

70 days